TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2672065

Group type: EXPERIMENTAL
Intervention: 250 mg of caffeine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (3 mg)
Number of subjects: 48
Study: 770365

Group type: EXPERIMENTAL
Intervention: nialamide + l-5-HTP
Number of subjects: 30

Group type: COMPARATOR
Intervention: nialamide
Number of subjects: 30
Study: 31541633

Group type: EXPERIMENTAL
Intervention: New risk model for predicting in-hospital mortality
Number of subjects: 56776

Group type: EXPERIMENTAL
Intervention: New risk model
Number of subjects: 56776
Study: 31111697

Group type: EXPERIMENTAL
Intervention: Fully Convolutional Networks (FCN) model
Number of subjects: 900
Study: 28040825

Group type: EXPERIMENTAL
Intervention: SDM-training (five sessions)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Non-specific group training (five sessions)
Number of subjects: 264
Study: 26541963

Group type: EXPERIMENTAL
Intervention: Mentor Support by mentors with a visual impairment in combination with care-as-usual
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mentor Support by mentors without visual impairments in combination with care-as-usual
Number of subjects: 120

Group type: COMPARATOR
Intervention: Care-as-usual only
Number of subjects: 120
Study: 23433656

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH) 0.1 IU kg(‐1) day(‐1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 22025856

Group type: EXPERIMENTAL
Intervention: Olopatadine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rupatadine
Number of subjects: 70
Study: 19726399

Group type: EXPERIMENTAL
Intervention: Supportive care (health education pamphlets, three sessions of individual health education and emotional support, two follow-up telephone counseling sessions)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 122
Study: 17291931

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP)
Number of subjects: 50
Study: 15089331

Group type: EXPERIMENTAL
Intervention: Stochastic heart-rate model
Number of subjects: 15
Study: 11318844

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sulphonylurea
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 54
Study: 9152683

Group type: EXPERIMENTAL
Intervention: 30 mg/d beta-carotene and placebo for alpha-tocopherol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: beta-carotene plus 400 IU alpha-tocopherol for ten weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy Austrian subjects, n = 13)
Number of subjects: 21
Study: 7686028

Group type: EXPERIMENTAL
Intervention: Iloprost (3000 ng infused into the graft)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (no iloprost infusion)
Number of subjects: 83
Study: 2979675

Group type: EXPERIMENTAL
Intervention: Enisoprost 100 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enisoprost 200 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enisoprost 400 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29493474

Group type: EXPERIMENTAL
Intervention: PACE label on familiar snack foods
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (no PACE label)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Unfamiliar snacks
Number of subjects: 153
Study: 27260515

Group type: EXPERIMENTAL
Intervention: 50% sleep restriction with an advanced wake-time
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 50% sleep restriction with a delayed bedtime
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sleep architecture (polysomnography)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (habitual bed‐ and wake‐times)
Number of subjects: 18
Study: 25187667

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (2.4g/day) for 7 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Aspirin (300 mg/day) from day 5 to day 7
Number of subjects: 21
Study: 22208477

Group type: EXPERIMENTAL
Intervention: Liu Wei Di Huang Wan (LDW) 4.8 g (12 pills, 0.2 g/pill, twice daily) for 14 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 20061436

Group type: EXPERIMENTAL
Intervention: Exercise group (combined aerobic/resistive exercise training)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (strict 60-day bed rest)
Number of subjects: 16
Study: 17287406

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Radioiodine treatment
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Low free triiodothyronine
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Elevated thyrotropin receptor antibody
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Thyroid hormone state (including subclinical thyrotoxicosis)
Number of subjects: 179
Study: 15640980

Group type: EXPERIMENTAL
Intervention: Customized wrist splints worn at night for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ergonomic education alone
Number of subjects: 0
Study: 12375297

Group type: EXPERIMENTAL
Intervention: CACE estimation approach
Number of subjects: 0
Study: 9989193

Group type: EXPERIMENTAL
Intervention: Single chamber atrial pacing
Number of subjects: 225

Group type: COMPARATOR
Intervention: Single chamber ventricular pacing
Number of subjects: 225
Study: 8527074

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) plus lymphoblastoid interferon (IFN)-alpha
Number of subjects: 402

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) alone
Number of subjects: 402
Study: 1573098

Group type: EXPERIMENTAL
Intervention: Home care preoperative teaching programme
Number of subjects: 0
Study: 4040337

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 155

Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Unilateral myringotomy and ventilating tube insertion
Number of subjects: 155
Study: 29353440

Group type: EXPERIMENTAL
Intervention: Playing Kaledo over 20 sessions
Number of subjects: 1313

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1313
Study: 27417177

Group type: EXPERIMENTAL
Intervention: Ice massage (IM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tap water massage (TWM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prone rest (PR)
Number of subjects: 30
Study: 26637849

Group type: EXPERIMENTAL
Intervention: Levonorgestrel‐impregnated intrauterine system (LNG‐IUS)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Oral progestin (10 mg medroxyprogesterone acetate (MPA) taken continuously)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Oral progestin (10 mg MPA taken 10 days per cycle for six months)
Number of subjects: 141
Study: 23073567

Group type: EXPERIMENTAL
Intervention: Wireless fluid monitoring using OptiVol alerts and ICD remote monitoring (RM)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 180
Study: 20810107

Group type: EXPERIMENTAL
Intervention: Cetrorelix (GnRH antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without cetrorelix)
Number of subjects: 0
Study: 19178095

Group type: EXPERIMENTAL
Intervention: Intensive treatment (InT) performed within 24 hours
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional treatment (CoT) with one treatment session a week for 4 weeks
Number of subjects: 25
Study: 16601570

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 12975252

Group type: EXPERIMENTAL
Intervention: Stent-assisted PCI
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Both CABG and stent-assisted PCI
Number of subjects: 988
Study: 11069135

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Imipramine plus supportive psychotherapy
Number of subjects: 101
Study: 9497696

Group type: EXPERIMENTAL
Intervention: TIVA using propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional thiopentone/isoflurane/nitrous oxide technique
Number of subjects: 0
Study: 2295232

Group type: EXPERIMENTAL
Intervention: RRKTT (oscillating bed)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional bed (control)
Number of subjects: 106
Study: 453892

Group type: EXPERIMENTAL
Intervention: SEUV TG (suberythemogenic ultraviolet phototherapy with tar gel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified Goeckerman (erythemogenic tar gel phototherapy regimen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tar gel alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: SEUV irradiation following application of gel vehicle
Number of subjects: 0
Study: 31323562

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) using radiofrequency ultrasound images
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional ultrasound techniques
Number of subjects: 131
Study: 28376855

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 24983350

Group type: EXPERIMENTAL
Intervention: MVG 1.3% once daily for 1 day
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: MVG 1.3% once daily for 3 days
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: MVG 1.3% once daily for 5 days
Number of subjects: 255

Group type: COMPARATOR
Intervention: MVG 0.75% once daily for 5 days
Number of subjects: 255
Study: 23183264

Group type: EXPERIMENTAL
Intervention: Baseline anxiety symptoms
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Early change in anxiety
Number of subjects: 250

Group type: COMPARATOR
Intervention: Baseline social stressors
Number of subjects: 250

Group type: COMPARATOR
Intervention: Early change in social stressors
Number of subjects: 250
Study: 22205930

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination
Number of subjects: 16402

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV (vCP1521)
Number of subjects: 16402

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16402
Study: 19234890

Group type: EXPERIMENTAL
Intervention: Hoffman compact II fixator (H group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dynawrist fixator (D group)
Number of subjects: 75
Study: 16403097

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 18
Study: 12928870

Group type: EXPERIMENTAL
Intervention: Imidacloprid 10% w/v / Permethrin 50% w/v combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 0
Study: 10945514

Group type: EXPERIMENTAL
Intervention: Combination hydrocodone 7.5 mg and ibuprofen 200 mg (2-tablet dose)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Combination hydrocodone 7.5 mg and ibuprofen 200 mg (1-tablet dose)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Combination codeine 30 mg and acetaminophen 300 mg (2-tablet dose)
Number of subjects: 469
Study: 9112450

Group type: EXPERIMENTAL
Intervention: 5-week radiotherapy schedule (66 Gy in 2 Gy/fraction)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 4-week radiotherapy schedule (66 Gy in 2 Gy/fraction)
Number of subjects: 40
Study: 8495454

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg plus paracetamol 1 g
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Domperidone 30 mg plus paracetamol 1 g
Number of subjects: 46

Group type: COMPARATOR
Intervention: Paracetamol 1 g alone
Number of subjects: 46
Study: 3545152

Group type: COMPARATOR
Intervention: 4',6-Dichloroflavan (40 mg; 5 times per day) administered intranasally as a 5% w/v aqueous suspension for 5 doses before and 21 doses after rhinovirus challenge.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 49
Study: 31728671

Group type: EXPERIMENTAL
Intervention: Group A (attending surgeon performed all four cardinal steps)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Group B (trainee involved in at least one cardinal step)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Group C (attending performs the whole case)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Group D (trainee performed at least one non-cardinal step)
Number of subjects: 12
Study: 28872388

Group type: EXPERIMENTAL
Intervention: Underweight/Normal weight
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Overweight/Obese
Number of subjects: 61

Group type: COMPARATOR
Intervention: Normal weight/Underweight
Number of subjects: 61
Study: 27758944

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg once daily for 90 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment in patients receiving tissue‐type plasminogen activator
Number of subjects: 104
Study: 23494629

Group type: EXPERIMENTAL
Intervention: 200‐U onabotulinumtoxinA injections
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 300‐U onabotulinumtoxinA injections
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 72
Study: 23635051

Group type: EXPERIMENTAL
Intervention: Medicaid coverage
Number of subjects: 12229

Group type: COMPARATOR
Intervention: Control group (not selected for Medicaid)
Number of subjects: 12229
Study: 19521435

Group type: EXPERIMENTAL
Intervention: Visante-OCT
Number of subjects: 101

Group type: COMPARATOR
Intervention: SL-OCT
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both AS-OCT devices
Number of subjects: 101
Study: 18416472

Group type: EXPERIMENTAL
Intervention: Posterior pelvic exenteration (PPE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard resection
Number of subjects: 10
Study: 16183426

Group type: EXPERIMENTAL
Intervention: Anti-LAM test
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: TST and anti-LAM test
Number of subjects: 143
Study: 12928982

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg daily) after a montelukast-free period of one day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg daily) after a montelukast-free period of three days
Number of subjects: 16
Study: 10026401

Group type: EXPERIMENTAL
Intervention: Kerasal 5% ointment
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Salicylic acid 5% in petrolatum
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Salicylic acid 10% in petrolatum
Number of subjects: 9
Study: 9017737

Group type: EXPERIMENTAL
Intervention: Odor present during recall after 5 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Odor present during recall after 15 min. and after 5 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: No odor present during any recall phase
Number of subjects: 40

Group type: COMPARATOR
Intervention: No odor present during recall after 5 days
Number of subjects: 40
Study: 2003053

Group type: EXPERIMENTAL
Intervention: Cephalosporins
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Penicillins
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Erythromycin (Ilosone)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Erythromycin ES
Number of subjects: 30
Study: 6469092

Group type: EXPERIMENTAL
Intervention: Periaortic lymph node metastases
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Recurrence
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Recurrences
Number of subjects: 98
Study: 30768550

Group type: EXPERIMENTAL
Intervention: HIIT (3‐min intervals at 40% and 80% V˙O2 reserve, n = 15)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MICT (sustained 60% V˙O2 reserve, n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study: 29190545

Group type: EXPERIMENTAL
Intervention: Combined exercise (aerobic and resistance)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined exercise and resistance exercise
Number of subjects: 47
Study: 27333960

Group type: EXPERIMENTAL
Intervention: Siberian ginseng powder
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 24947287

Group type: EXPERIMENTAL
Intervention: High-dose edoxaban
Number of subjects: 21105

Group type: EXPERIMENTAL
Intervention: Low-dose edoxaban
Number of subjects: 21105

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105
Study: 22205098

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronan injection
Number of subjects: 57

Group type: COMPARATOR
Intervention: No intra-articular hyaluronan injection (non-injection group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison between injection and non-injection groups
Number of subjects: 57
Study: 19757275

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 17513645

Group type: EXPERIMENTAL
Intervention: Balsol (magnesium 1.5 g/L)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Balsol plus additional magnesium (magnesium 3.0 g/L)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 25
Study: 15181783

Group type: EXPERIMENTAL
Intervention: Temporal processing training program consisting of auditory and visual order threshold and sound localisation tasks over a period of eight weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 42
Study: 11597539

Group type: EXPERIMENTAL
Intervention: Free and total PSA measurements in black participants (n = 868, 12%)
Number of subjects: 7183

Group type: EXPERIMENTAL
Intervention: Free and total PSA measurements in Hispanic participants (n = 339, 4.7%)
Number of subjects: 7183

Group type: EXPERIMENTAL
Intervention: Free and total PSA measurements across age groups
Number of subjects: 7183

Group type: EXPERIMENTAL
Intervention: Free and total PSA measurements based on history of benign prostatic disease
Number of subjects: 7183

Group type: EXPERIMENTAL
Intervention: %fPSA measurements across racial groups and age
Number of subjects: 7183
Study: 9620898

Group type: COMPARATOR
Intervention: HR3 (rifampin plus isoniazid, 3 times weekly)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: HRp1 (rifapentine plus isoniazid, once weekly)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: HRp1.2/3 (rifapentine plus isoniazid, on 2 of 3 weeks)
Number of subjects: 672
Study: 7890009

Group type: EXPERIMENTAL
Intervention: HELP-apheresis treatment
Number of subjects: 39
Study: 2660333

Group type: EXPERIMENTAL
Intervention: ABO-matched random-donor platelet transfusions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Second matched transfusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mismatched transfusions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Matched and mismatched platelet transfusions
Number of subjects: 60
Study: 31138063

Group type: EXPERIMENTAL
Intervention: Half normal saline (0.45% saline in 5% dextrose)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Normal saline (0.9% saline in 5% dextrose)
Number of subjects: 168
Study: 30860114

Group type: EXPERIMENTAL
Intervention: Preoperative DTI (Diffusion Tensor Imaging)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non DTI (Control group)
Number of subjects: 94
Study: 28338403

Group type: EXPERIMENTAL
Intervention: E‐Moms (personalized health intervention via SmartPhone)
Number of subjects: 40

Group type: COMPARATOR
Intervention: WIC Moms (usual care)
Number of subjects: 40
Study: 25789568

Group type: EXPERIMENTAL
Intervention: Jaw-thrust manoeuvre in the 25° semi-sitting position
Number of subjects: 88

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 88
Study: 22992296

Group type: EXPERIMENTAL
Intervention: Combination nicotine replacement therapy (NRT) for 6 weeks
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Combination NRT for 2 weeks
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Nicotine patch alone for 6 weeks
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Standard 4-call counseling (SC) plus medication adherence counseling (MAC)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: 2-week combination NRT
Number of subjects: 987

Group type: COMPARATOR
Intervention: 2-week nicotine patch only
Number of subjects: 987

Group type: COMPARATOR
Intervention: 6-week nicotine patch only
Number of subjects: 987

Group type: COMPARATOR
Intervention: 6-week combination NRT
Number of subjects: 987
Study: 21600843

Group type: EXPERIMENTAL
Intervention: Real rTMS (5 Hz, 900 stimuli) applied on 5 consecutive days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study: 19686085

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16403040

Group type: EXPERIMENTAL
Intervention: MoodGYM Mark II (new public version requiring compulsory completion of core assessments)
Number of subjects: 58200

Group type: COMPARATOR
Intervention: MoodGYM Mark I (original site)
Number of subjects: 58200

Group type: EXPERIMENTAL
Intervention: MoodGYM intervention (both versions)
Number of subjects: 58200
Study: 15320650

Group type: EXPERIMENTAL
Intervention: 5-day creatine monohydrate supplementation (0.3 g.kg(‐1).d(‐1))
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 5-day creatine monohydrate supplementation
Number of subjects: 11
Study: 15001036

Group type: EXPERIMENTAL
Intervention: Abstained from eating during cue reactivity assessment
Number of subjects: 135

Group type: COMPARATOR
Intervention: Ate during cue reactivity assessment
Number of subjects: 135
Study: 9262289

Group type: EXPERIMENTAL
Intervention: Cryopreserved embryos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresh embryos
Number of subjects: 0
Study: 8250078

Group type: EXPERIMENTAL
Intervention: Nidek 3Dx system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Donaldson camera
Number of subjects: 100